Identification

Namequillaia
IUPACquillaja saponaria molina
CAS Number977002-27-9
FDA UNIISearch

Regulatory

FDA Mainterm (SATF)977002-27-9 ; QUILLAIA (QUILLAJA SAPONARIA MOLINA)
FDA RegulationFDA PART 172 -- FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR HUMAN CONSUMPTION

Physical Properties

Food Chemicals Codex Listed No

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categoryspices, other natural seasonings and flavorings
Recommendation for quillaia usage levels up tonot for fragrance use.
Recommendation for quillaia flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

bronchitis

Natural Occurrence

quillaja saponaria molina

Synonyms

quillaja saponaria molina soapbark PubMed: Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina. PubMed: Phenolic constituents in commercial aqueous Quillaja (Quillaja saponaria Molina) wood extracts. PubMed: Influence of Quil A on liposomal membranes. PubMed: In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles. PubMed: Interaction of Quillaja bark saponins with food-relevant proteins. PubMed: Unusual penetration of phospholipid mono- and bilayers by Quillaja bark saponin biosurfactant. PubMed: Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice. PubMed: Effects of saponin extracts on air emissions from steers. PubMed: Electrospray ionization ion-trap multiple-stage mass spectrometry of Quillaja saponins. PubMed: Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina. PubMed: Ultrasonically enhanced extraction of bioactive principles from Quillaja Saponaria Molina. PubMed: Prevention of rotavirus infections in vitro with aqueous extracts of Quillaja Saponaria Molina. PubMed: Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index. PubMed: Multidimensional profiling of components in complex mixtures of natural products for metabolic analysis, proof of concept: application to Quillaja saponins. PubMed: Advances in saponin-based adjuvants. PubMed: Structural classification of acyl-substituted Quillaja saponins by electrospray ionisation ion trap multiple-stage mass spectrometry in combination with multivariate analysis. PubMed: Antiviral activity obtained from aqueous extracts of the Chilean soapbark tree (Quillaja saponaria Molina). PubMed: Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs). PubMed: Assessment of the monoterpene, glycidic and triterpene-moieties' contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth during vaccination against experimental visceral leishmaniasis. PubMed: Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis. PubMed: Exposure of tilapia pituitary cells to saponins: insight into their mechanism of action. PubMed: Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis. PubMed: Metabolomic analysis of saponins in crude extracts of Quillaja saponaria by liquid chromatography/mass spectrometry for product authentication. PubMed: Oligosaccharide sequences in Quillaja saponins by electrospray ionization ion trap multiple-stage mass spectrometry. PubMed: Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria. PubMed: Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine. PubMed: QS-21 structure/function studies: effect of acylation on adjuvant activity. PubMed: Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. PubMed: Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity. PubMed: Structural studies of triterpenoid saponins with new acyl components from Quillaja saponaria Molina. PubMed: Novel acetylated triterpenoid saponins in a chromatographic fraction from Quillaja saponaria Molina. PubMed: Characterization of some O-acetylated saponins from Quillaja saponaria Molina. PubMed: Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity. PubMed: Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines. PubMed: ISCOMs and other saponin based adjuvants. PubMed: Triterpenoid saponins containing an acetylated branched D-fucosyl residue from Quillaja saponaria Molina. PubMed: Separation and structural analysis of some saponins from Quillaja saponaria Molina. PubMed: Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A. PubMed: Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina. PubMed: ISCOMs: an adjuvant with multiple functions. PubMed: Triterpenoid saponins from Quillaja saponaria. PubMed: QS-21 and QS-7: purified saponin adjuvants. PubMed: Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity. PubMed: In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations. PubMed: In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids. PubMed: Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy. PubMed: Molecular structures of saponins from Quillaja saponaria Molina. PubMed: Isomerization and formulation stability of the vaccine adjuvant QS-21. PubMed: A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics. PubMed: Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms. PubMed: A 4-methyl-7-hydroxyphthalide glycoside and other constituents from Quillaja saponaria molina. PubMed: Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix. PubMed: Effect of saponin from Quillaja saponaria (molina) on antibody, tumour necrosis factor and interferon-gamma production. PubMed: Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines. PubMed: Glycosyl compositions and structural characteristics of the potential immuno-adjuvant active saponins in the Quillaja saponaria Molina extract quil A. PubMed: Development of a genetically engineered vaccine against feline leukemia virus infection. PubMed: Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. PubMed: Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. PubMed: Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines.